Ani Pharmaceuticals (ANIP) Goodwill & Intangibles (2016 - 2025)
Ani Pharmaceuticals (ANIP) has disclosed Goodwill & Intangibles for 14 consecutive years, with $542.0 million as the latest value for Q4 2025.
- Quarterly Goodwill & Intangibles fell 9.94% to $542.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $542.0 million through Dec 2025, down 9.94% year-over-year, with the annual reading at $542.0 million for FY2025, 9.94% down from the prior year.
- Goodwill & Intangibles hit $542.0 million in Q4 2025 for Ani Pharmaceuticals, down from $562.3 million in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $630.3 million in Q3 2024 to a low of $32.5 million in Q2 2023.
- Historically, Goodwill & Intangibles has averaged $325.9 million across 5 years, with a median of $273.4 million in 2022.
- Biggest five-year swings in Goodwill & Intangibles: crashed 89.08% in 2023 and later surged 549.73% in 2024.
- Year by year, Goodwill & Intangibles stood at $322.0 million in 2021, then fell by 13.1% to $279.8 million in 2022, then fell by 15.23% to $237.2 million in 2023, then skyrocketed by 153.69% to $601.8 million in 2024, then dropped by 9.94% to $542.0 million in 2025.
- Business Quant data shows Goodwill & Intangibles for ANIP at $542.0 million in Q4 2025, $562.3 million in Q3 2025, and $76.3 million in Q2 2025.